EL-25 · Research peptide
No reviews yet. Be the first to share your experience.
Tier I · Synthesis QC
Tier I · Synthesis QC
In-house · per step
RP-HPLC, MS confirmation, sequence verification in cleanroom.
Tier II · In-process
Tier II · In-process
Batch · final
Identity, purity, and assay before release.
Tier III · Third-party lab
Tier III · Third-party lab
External · independent
HPLC, ICP-MS, and microbiology by accredited lab.
953
satisfied
99.41%
Avg. purity 2026
4.8 ★
Store rating
EL-25 · Reference data
GHRH-Analog · langwirksam (DAC-konjugiert)
Aliases: CJC-1295 mit DAC · DAC:GRF
Research Use Only (RUO)
Research Use Only
For research purposes only (RUO). Not for human consumption.
| Molecule | CJC-1295 with DAC (DAC:GRF) |
| Sequence | D-Ala-Gln-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg + Lys(MPA) |
| CAS | 863288-34-0 |
| Molecular weight | 3.368 kDa without DAC, 4.545 kDa DAC-modified |
| Form | Lyophilized powder |
| Fill per vial | 10 mg |
| Purity | ≥99 % (HPLC) |
Each lot of CJC-1295 undergoes chromatographic purity testing alongside a mass-based identity check to confirm the DAC-conjugated structure. These findings are documented on a certificate tied to that specific batch number. Rather than accompanying every order automatically, the certificate is released by the support desk once a request has been received and processed.
The lyophilized powder should be kept refrigerated at 2 to 8 °C and out of direct light before use. Once a sterile solvent is added in the laboratory, the resulting solution should be used without delay, since no long-term stability data for the reconstituted state is provided. No volume, concentration, or application guidance accompanies this reagent, and any preparation choices remain at the discretion of the laboratory.
Distribution of CJC-1295 is limited to research use only (RUO); it is not intended for use in or on humans or animals and carries no status as a medicine, foodstuff, or cosmetic component. Compliance obligations sit with the receiving laboratory. As a long-acting GHRH analog, the molecule is discussed in the literature within growth-hormone-releasing-hormone receptor pharmacology and endocrine cell signaling models, and no outcome in a living organism is implied by that reference.
To receive the certificate of analysis, send the batch number from the vial label to Eurolabs Peptides support by email. The certificate documents the HPLC purity trace and the identity result recorded for that production run.
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.41% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
The reagent is manufactured to ≥99 % purity as measured by HPLC, with each production lot verified individually and documented on its own certificate of analysis.
Yes, this reference material corresponds to CJC-1295 with DAC (also referred to as DAC:GRF), a long-acting GHRH analog distinct from the unmodified Mod GRF 1-29 fragment.
Keep the lyophilized vial refrigerated at 2 to 8 °C, protected from light, until reconstitution in the laboratory shortly before the reagent is needed for an assay.
Email support with the lot number printed on the label. The certificate returned lists the HPLC purity figure and identity confirmation specific to that manufacturing batch.
0.9% benzyl alcohol
€14.99
BAC-Water 10ML
Default Category
BPC-157
Default Category
GHK-Cu
Default Category
Glow Stack (GHK-Cu 50mg, TB-500 10mg, BPC-157 10mg)
Default Category
Klow (GHK-Cu 25mg, TB500 10mg, BPC157 10mg, KPV 10mg)
Default Category
KPV
Default Category
MOTS-c 10mg
Default Category
Melanotan II 10mg
Default Category
